Adial Pharmaceuticals Inc Business Update Call Transcript
Good day, ladies and gentlemen, and welcome to your Adial Pharmaceuticals business update call. (Operator Instructions). At this time it's my pleasure to turn the floor over to your host David Waldman, Investor Relations. Sir, the floor is yours.
Good morning and thank you for joining Adial Pharmaceuticals' business and clinical update conference call. On the call with us today is William Stilley, Chief Executive Officer. If you have any questions after the call or would like any additional information about the Company, please contact Crescendo Communications at 212-671-1020.
Before we get started we would like to remind everyone that this call contains certain forward-looking statements within the meaning of the US Federal Securities laws. Such statements are based upon various facts and derive utilizing numerous important assumptions and are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from any
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
